Women ages 18-50 with Uterine Fibroids and/or Endometriosis can participate to reduce their signs and symptoms.
You must be premenopausal and not pregnant or planning to become pregnant in the near future. In this study you will receive Elagolix or Relugolix in combination with Oral Contraceptives. You will also receive applicable study visits, exams, and labs.
To qualify, you will need a documented diagnosis of endometriosis, and/or fibroids which may be covered under the study. See if you qualify and/or let us answer your questions with the form below.
You can also give us a call OR text! 208-502-3039
